The US Food and Drug Administration (FDA) has approved an expanded indication of the intravenous (IV) formulation of South ...

Germany’s Bayer experienced a nightmare day’s trading Wednesday, with shares in the life sciences company more than 8% lower ...

Biologics-focused contract manufacturing and research organization Abenza announced that Geoffrey Glass has been appointed ...

Denmark’s Novo Nordisk saw its shares fall 4.8% to 291.20 kroner by early afternoon, after it posted financials results for ...

Intas Pharmaceuticals has introduced Hetronifly (serplulimab) in the Indian market. The therapy is the first PD-1 inhibitor ...

Japanese drugmaker Nxera Pharma has unveiled a slate of new programs targeting obesity and related metabolic diseases, ...

US specialty pharma business SERB Pharmaceuticals is acquiring Y-mAbs Therapeutics (Nasdaq: YMAB) in a $412 million all-cash ...

Pharmaceutical regulation is undergoing its biggest shake-up in decades. On both sides of the Atlantic, policymakers are ...

Danish diabetes and obesity giant Novo Nordisk has announced the filing of 14 new lawsuits to safeguard patients from unsafe ...

Further evidence that US Department of Health and Human Services (HHS) secretary Robert F Kennedy Junior (RFK Jr) is willing ...

The UK’s National Institute for Health and Care Excellence (NICE) on August 6 recommended the use of US pharma giant Merck & ...

US biotech major Amgen announced financial results for the second quarter of 2025 after market closed on Tuesday, with ...